Breast cancer is one of the deadliest diseases nowadays. It kills more women annually than any other disease and even if they survive, the consequences are great.
According to experts, 1 in every 8 women will develop breast cancer at some point of their life. However, there is hope after all, as a team of scientists from Amsterdam, The Netherlands has been able to find a potential cure which can save the lives of millions of women!
The results were presented at the European Breast Cancer Conference in Amsterdam by professor Nigel Bundred. The study had the goal of examining the effects of drugs such as Lapatinib and Herceptin, two common chemotherapy drugs which were used in combination for the first time. The scientists used the combination on breast cancer patients before they decided on chemo or radiation. The results were stunning – the combination of both drugs destroyed almost all the cancer cells in most of the patient after only 11 days!
The study was funded by Cancer Research UK. The scientists discovered that the combination of Lapatinib and Herceptin effectively inhibited the action of a protein known as HER2 (Human Epidermal Growth Factor Receptor 2). This protein affects cell division and cancer cell development as well. This means that inhibiting its action can prevent the development of breast cancer cells and prevent the deadly disease from destroying your life.
Even better, the combination of drugs worked far better than chemo and radiation and without their terrible side-effects including hair loss, nausea and fatigue. The good news is that more and more people are becoming aware of the dangers of chemotherapy and radiation and many cancer patients are now willing to try alternative treatments before deciding to get conventionally treated.
The study was performed on 257 women positive on HER2 breast cancer. 50% of these women were in the control group who received only Herceptin, while the rest were using a combination of the drugs.
The results showed that only 11% of the women who took the combination of drugs had no traces of cancer cells after 11 days, while 17% of the women experienced significantly shrunk tumors. In the control group, only 3% of women had shrunken tumors while none of them were able to destroy all the cancer cells.
The study is very promising and shows that the combination of these drugs may be the cure for cancer. It is a revolutionary study as not many scientists before it have actually tried searching for a cure in this direction. However, there’s a slight problem – both Lapatinib and Herceptin are licensed for use in chemotherapy only, so if this doesn’t change soon, this potential cure for cancer may never see the light of day. The research is a huge step towards the elusive cure for cancer, but more research needs to be done before it’s fully accepted by the scientific community.
Article and image source: https://readanddigest.com